葡萄膜炎患者的健康相关生活质量研究
结果显示,视力越差,HRQOL越低;较差眼视力差、双眼患病和合并青光眼性视神经病变是TTO HRQOL较差的预测因素,而病程、葡萄膜炎发作或全身治疗与HRQOL无关。
要点
- 葡萄膜炎患者平均TTO效用值为0.831,SG效用值为0.868,EQ5D-5L效用值为0.742。
- 视力与HRQOL呈负相关:视力6/12或更好者TTO为0.86,6/15-6/60者为0.662,差于6/60者为0.608。
- 较差眼视力差(p=0.004)、双眼患病(p=0.047)和合并青光眼性视神经病变(p=0.005)是TTO HRQOL较差的预测因素。
核心结论
- 葡萄膜炎导致的视力丧失与健康相关生活质量降低相关。
- TTO和SG效用值直接取决于视力丧失程度,而非疾病病程或全身用药。
研究设计与样本
- 连续纳入三级转诊葡萄膜炎门诊的患者,进行标准化访谈式TTO和SG问卷,并完成EQ5D-5L问卷。
主要发现
- 总体平均TTO效用值为0.831(95%CI 0.802至0.860),平均SG效用值为0.868(95%CI 0.840至0.896),平均EQ5D-5L效用值为0.742(95%CI 0.702至0.782)。
- 视力与平均HRQOL呈负相关:视力6/12或更好者TTO为0.86、SG为0.893;视力6/15-6/60者TTO为0.662、SG为0.742;视力差于6/60者TTO为0.608、SG为0.712。
- 较差眼视力差(p=0.004)、双眼患病(p=0.047)和合并青光眼性视神经病变(p=0.005)是TTO HRQOL较差的预测因素。
- HRQOL与确诊病程、葡萄膜炎发作或正在接受全身治疗之间未发现相关性。
- 视力差的葡萄膜炎患者TTO值劣于接受血液透析的终末期肾衰竭患者或艾滋病患者。
临床怎么用
- 在葡萄膜炎患者管理中应关注视力丧失对健康相关生活质量的影响,尤其是较差眼视力差、双眼患病或合并青光眼性视神经病变者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To measure health-related quality of life (HRQOL) in patients with uveitis using time trade-off (TTO) and standard gamble (SG) methods of direct utility analysis. METHODS: Consecutive patients attending a tertiary referral uveitis clinic were administered standardised, interview-delivered TTO and SG questionnaires and completed the European Quality of Life Five Dimensions Five Level (EQ5D-5L) questionnaire. Clinical data recorded included best-corrected visual acuity, uveitis anatomical and clinical classifications, duration since diagnosis, disease activity, current medication and any ocular or systemic comorbidities. RESULTS: Two hundred patients with uveitis (124 female, 76 male, median age 54 years) were included. Overall mean TTO utility was 0.831 (95% CI 0.802 to 0.860); mean SG utility was 0.868 (95% CI 0.840 to 0.896) and mean EQ5D-5L utility was 0.742 (95% CI 0.702 to 0.782). There was a negative correlation between visual acuity and mean HRQOL (6/12 or better: TTO 0.86, SG 0.893; 6/15-6/60: TTO 0.662, SG 0.742; worse than 6/60: TTO 0.608, SG 0.712). Poor vision in the better- seeing eye (p=0.004), bilateral disease (p=0.047) and concurrent glaucomatous optic neuropathy (p=0.005) were predictors of poor TTO HRQOL. No correlation was found between HRQOL and duration of diagnosis, a flare of uveitis or being on systemic therapy. Patients with uveitis with poor vision have a TTO value worse than patients with end-stage renal failure on haemodialysis or those with AIDS. CONCLUSION: Loss of vision resulting from uveitis is associated with reduced HRQOL. The TTO and SG utility values appear directly dependent on the degree of vision loss and not on the duration of disease or systemic medications.
引用
- Shamdas M, Bassilious K, Murray PI, et al. Health-related quality of life in patients with uveitis. Br J Ophthalmol. 2018. PMID: 30361275. doi:10.1136/bjophthalmol-2018-312882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。